Clinical Trial: Evaluation of Side Effects of Mitotane

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Evaluierung Von Nebenwirkungen Einer Therapie Mit Mitotane Beim Nebennierenkarzinom- Evaluation of Side Effects of Mitotane in Adrenocortical Carcinoma

Brief Summary: Mitotane is standard therapy in the treatment of adrenocortical carcinoma. However, many side effects are not well documented. Therefore, we are aiming at collecting data about side effects in patients treated with mitotane

Detailed Summary:
Sponsor: University of Wuerzburg

Current Primary Outcome: Documentation of side effects [ Time Frame: 3 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Wuerzburg

Dates:
Date Received: December 4, 2007
Date Started: January 2008
Date Completion: December 2019
Last Updated: October 28, 2016
Last Verified: October 2016